3'UTR shortening identifies high-risk cancers with targeted dysregulation of the ceRNA network

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Li, Li ^a   Wang, Duolin ^b   Xue, Mengzhu ^a   Mi, Xianqiang ^a   Liang, Yanchun ^b   Wang, Peng ^a,c  

^a SHANGHAI ADVANCED RESEARCH INSTITUTE   (China)

^b JILIN UNIVERSITY   (China)

^c SHANGHAITECH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3' UNTRANSLATED REGION; GENETIC MARKER; MICRORNA; RNA;

3' UNTRANSLATED REGION; CELL CULTURE; GENE EXPRESSION REGULATION; GENE TARGETING; GENETIC MARKER; GENETICS; HUMAN; MALE; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PROCEDURES; PROSTATE TUMOR; RISK ASSESSMENT; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION;

3' UNTRANSLATED REGIONS; BASE SEQUENCE; CELLS, CULTURED; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE TARGETING; GENETIC MARKERS; HUMANS; MALE; MICRORNAS; MOLECULAR SEQUENCE DATA; PROSTATIC NEOPLASMS; RISK ASSESSMENT; RNA, NEOPLASM; SEQUENCE ANALYSIS, RNA; SIGNAL TRANSDUCTION;

EID: 84903200695     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep05406     Document Type: Article

References (43)

1. Bartel, D. P. MicroRNAs: target recognition and regulatory functions. Cell 136, 215-233, doi:10.1016/j.cell.2009.01.002 (2009).
2. Vasudevan, S., Tong, Y. & Steitz, J. A. Switching from repression to activation: microRNAs can up-regulate translation. Science 318, 1931-1934, doi:10.1126/science.1149460 (2007).
3. Guo, H., Ingolia, N. T., Weissman, J. S. & Bartel, D. P. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466, 835-840, doi:10.1038/nature09267 (2010).
4. Tay, Y., Rinn, J. & Pandolfi, P. P. The multilayered complexity of ceRNA crosstalk and competition. Nature 505, 344-352, doi:10.1038/nature12986 (2014).
5. Salmena, L., Poliseno, L., Tay, Y., Kats, L. & Pandolfi, P. P. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell 146, 353-358, doi:10.1016/j.cell.2011.07.014 (2011).
6. Sumazin, P. et al. An extensive microRNA-mediated network of RNA-RNA interactions regulates established oncogenic pathways in glioblastoma. Cell 147, 370-381, doi:10.1016/j.cell.2011.09.041 (2011).
7. Tay, Y. et al. Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs. Cell 147, 344-357, doi:10.1016/j.cell.2011.09. 029 (2011).
8. Karreth, F. A. et al. In vivo identification of tumor-suppressive PTEN ceRNAs in an oncogenic BRAF-induced mouse model of melanoma. Cell 147, 382-395, doi:10.1016/j.cell.2011.09.032 (2011).
9. Forman, J. J., Legesse-Miller, A. & Coller, H. A. A search for conserved sequences in coding regions reveals that the let-7 microRNA targets Dicer within its coding sequence. Proceedings of the National Academy of Sciences of the United States of America 105, 14879-14884, doi:10.1073/pnas. 0803230105 (2008).
10. Lytle, J. R., Yario, T. A. & Steitz, J. A. Target mRNAs are repressed as efficiently by microRNA-binding sites in the 59 UTR as in the 39 UTR. Proceedings of the National Academy of Sciences of the United States of America 104, 9667-9672, doi:10.1073/pnas.0703820104 (2007).
11. Tian, B., Hu, J., Zhang, H. & Lutz, C. S. A large-scale analysis of mRNA polyadenylation of human and mouse genes. Nucleic acids research 33, 201-212, doi:10.1093/nar/gki158 (2005).
12. Sandberg, R., Neilson, J. R., Sarma, A., Sharp, P. A. & Burge, C. B. Proliferating cells express mRNAs with shortened 39 untranslated regions and fewer microRNA target sites. Science 320, 1643-1647, doi:10.1126/science.1155390 (2008).
13. Mayr, C. & Bartel, D. P. Widespread shortening of 39UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells. Cell 138, 673-684, doi:10.1016/j.cell.2009.06.016 (2009).
14. Lembo, A., Di Cunto, F. & Provero, P. Shortening of 39UTRs Correlates with Poor Prognosis in Breast and Lung Cancer. PloS one 7, e31129, doi:10.1371/journal.pone.0031129 (2012).
15. Singh, P. et al. Global changes in processing of mRNA 39 untranslated regions characterize clinically distinct cancer subtypes. Cancer research 69, 9422-9430, doi:10.1158/0008-5472.CAN-09-2236 (2009).
16. Lapuk, A. et al. Exon-Level Microarray Analyses Identify Alternative Splicing Programs in Breast Cancer. Molecular Cancer Research 8, 961-974, doi:10.1158/1541-7786.mcr-09-0528 (2010).
17. Smibert, P. et al. Global patterns of tissue-specific alternative polyadenylation in Drosophila. Cell reports 1, 277-289, doi:10.1016/j.celrep. 2012.01.001 (2012).
18. Miura, P., Shenker, S., Andreu-Agullo, C., Westholm, J. O. & Lai, E. C. Widespread and extensive lengthening of 39 UTRs in the mammalian brain. Genome research 23, 812-825, doi:10.1101/gr.146886.112 (2013).
19. Erdman, C. & Emerson, J. W. A fast Bayesian change point analysis for the segmentation of microarray data. Bioinformatics 24, 2143-2148, doi:10.1093/bioinformatics/btn404 (2008).
20. Erdman, C. & Emerson, J. W. bcp: An R Package for Performing a Bayesian Analysis of Change Point Problems. Journal of Statistical Software 23, 1-13 (2007).
21. Taylor, B. S. et al. Integrative genomic profiling of human prostate cancer. Cancer cell 18, 11-22, doi:10.1016/j.ccr.2010.05.026 (2010).
22. Fu, Y. et al. Differential genome-wide profiling of tandem 39 UTRs among human breast cancer and normal cells by high-throughput sequencing. Genome research 21, 741-747, doi:10.1101/gr.115295.110 (2011).
23. Salisbury, J., Hutchison, K. W., Wigglesworth, K., Eppig, J. J. & Graber, J. H. Probe-level analysis of expression microarrays characterizes isoform-specific degradation during mouse oocyte maturation. PloS one 4, e7479, doi:10.1371/journal.pone.0007479 (2009).
24. Spies, N., Burge, C. B. & Bartel, D. P. 39 UTR-isoform choice has limited influence on the stability and translational efficiency of most mRNAs in mouse fibroblasts. Genome research 23, 2078-2090, doi:10.1101/gr.156919.113 (2013).
25. Kiledjian, M., Wang, X. & Liebhaber, S. A. Identification of two KH domain proteins in the alpha-globin mRNP stability complex. The EMBO journal 14, 4357-4364 (1995).
26. Bracken, C. P. et al. A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Cancer research 68, 7846-7854, doi:10.1158/0008-5472.CAN-08-1942 (2008).
27. Ustach, C. V. & Kim, H. R. Platelet-derived growth factor D is activated by urokinase plasminogen activator in prostate carcinoma cells. Molecular and cellular biology 25, 6279-6288, doi:10.1128/MCB.25.14.6279-6288. 2005 (2005).
28. Huang da, W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature protocols 4, 44-57, doi:10.1038/nprot.2008.211 (2009).
29. Tusher, V. G., Tibshirani, R. & Chu, G. Significance analysis of microarrays applied to the ionizing radiation response. Proceedings of the National Academy of Sciences of the United States of America 98, 5116-5121, doi:10.1073/pnas.091062498 (2001).
30. Grimson, A. et al. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Molecular cell 27, 91-105, doi:10.1016/j.molcel.2007.06.017 (2007).
31. Kertesz, M., Iovino, N., Unnerstall, U., Gaul, U. & Segal, E. The role of site accessibility in microRNA target recognition. Nature genetics 39, 1278-1284, doi:10.1038/ng2135 (2007).
32. John, B. et al. Human MicroRNA targets. PLoS biology 2, e363, doi:10.1371/journal.pbio.0020363 (2004).
33. Kwabi-Addo, B. et al. Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression. Proceedings of the National Academy of Sciences of the United States of America 98, 11563-11568, doi:10.1073/pnas.201167798 (2001).
34. Ala, U. et al. Integrated transcriptional and competitive endogenous RNA networks are cross-regulated in permissive molecular environments. Proceedings of the National Academy of Sciences of the United States of America 110, 7154-7159, doi:10.1073/pnas.1222509110 (2013).
35. Kumar, M. S. et al. HMGA2 functions as a competing endogenous RNA to promote lung cancer progression. Nature 505, 212-217, doi:10.1038/nature12785 (2014).
36. Aldana, M. & Cluzel, P. A natural class of robust networks. Proceedings of the National Academy of Sciences of the United States of America 100, 8710-8714, doi:10.1073/pnas.1536783100 (2003).
37. Cerami, E. et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer discovery 2, 401-404, doi:10.1158/2159-8290.CD-12-0095 (2012).
38. Bengtsson, H., Wirapati, P. & Speed, T. P. A single-array preprocessing method for estimating full-resolution raw copy numbers from all Affymetrix genotyping arrays including GenomeWideSNP 5 & 6. Bioinformatics 25, 2149-2156, doi:10.1093/bioinformatics/btp371 (2009).
39. Wilkerson, M. D. & Hayes, D. N. Consensus Cluster Plus: a class discovery tool with confidence assessments and item tracking. Bioinformatics 26, 1572-1573, doi:10.1093/bioinformatics/btq170 (2010).
40. Mani, K. M. et al. A systems biology approach to prediction of oncogenes and molecular perturbation targets in B-cell lymphomas. Molecular systems biology 4, 169, doi:10.1038/msb.2008.2 (2008).
41. Li, J. et al. Identification of high-quality cancer prognostic markers andmetastasis network modules. Nature communications 1, 34, doi:10.1038/ ncomms1033 (2010).
42. Zaman, N. et al. Signaling network assessment of mutations and copy number variations predict breast cancer subtype-specific drug targets. Cell reports 5, 216-223, doi:10.1016/j.celrep.2013.08.028 (2013).
43. Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome research 13, 2498-2504, doi:10.1101/gr.1239303 (2003).